Liver Cancer

Latest News

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com
New Developments Warrant Rethinking HCC Transplant Criteria

April 29th 2025

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

FDA Approved
Nivolumab With Ipilimumab Approved by FDA for Use in Hepatocellular Carcinoma

April 11th 2025

FDA building | Image Credit: © Tada Images - stock.adobe.com
Second CRL for Rivoceranib/Camrelizumab for Unresectable HCC

March 21st 2025

Top 5 liver cancer content of 2024 image graphic with health icons
Top 5 Most-Viewed Liver Cancer Content for 2024

December 27th 2024

Doctor with human liver anatomy model | Image credit: Jo Panuwat D - stock.adobe.com
Tislelizumab Pushes HCC Field Forward With 2024 NCCN Guideline Category 1 Recommendation

December 1st 2024

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo